Wellnex Life has successfully raised $14.3 million in funding to support its upcoming dual listing on the London Stock Exchange’s Alternative Investment Market (AIM). The company has garnered significant interest from both UK and Australian investors for a non-renounceable pro-rata entitlement offer, allowing eligible investors to subscribe for additional shares at an issue price of $0.65 each.

This move towards a dual listing on the London Stock Exchange represents a pivotal moment for Wellnex Life, positioning the company to access a broader capital base and investors with a strong understanding of consumer healthcare enterprises. By listing on the LSE, Wellnex Life anticipates not only financial benefits but also enhanced exposure and credibility as it expands its brand presence in the European market.

In addition to funding the dual listing, the raised capital will also be utilized to settle an outstanding deferred consideration for the acquisition of Pain Away, a prominent Australian topical pain relief brand. The integration of Pain Away into Wellnex Life has proven to be transformative, with the brand achieving record revenues exceeding $3 million in the final months of 2024. This success underscores the strategic value of the acquisition and the potential for further growth and market penetration.

The dual listing on the AIM is contingent upon Wellnex Life meeting the regulatory prerequisites for admission and successfully completing the capital raise process. The company expects to realize cost savings of $1.4 million by eliminating approximately $12.8 million in debt through this listing. Moreover, Wellnex Life is optimistic about leveraging the dual listing to fortify its financial position and capitalize on the expanding domestic and international consumer healthcare markets.

As Wellnex Life embarks on this significant corporate milestone, it joins the ranks of prominent consumer healthcare companies listed on the London Stock Exchange, signaling its commitment to growth and innovation in the sector. The company’s strategic decision to pursue a dual listing reflects its long-term vision and determination to create sustainable value for its stakeholders while solidifying its position in the global marketplace.